Priapism Associated With Antipsychotics: Role of α 1 Adrenoceptor Affinity
- Author
- ANDERSOHN, Frank1 ; SCHMEDT, Niklas2 ; WEINMANN, Stefan1 ; WILLICH, Stefan N1 ; GARBE, Edeltraut2
[1] Institute for Social Medicine, Epidemiology and Health Economics, Charité-University Medical Center, Berlin, Germany
[2] Bremen Institute for Prevention Research and Social Medicine, University of Bremen, Bremen, Germany - Source
Journal of clinical psychopharmacology. 2010, Vol 30, Num 1, pp 68-71, 4 p ; ref : 19 ref
- CODEN
- JCPYDR
- ISSN
- 0271-0749
- Scientific domain
- Cognition; Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antipsychotique atypique Antipsychotique Aripiprazole Base de données Chlorpromazine Effet secondaire Etiopathogénie Homme Hypnotique Médicament Neuroleptique Pharmacothérapie Pharmacovigilance Priapisme Psychotrope Quétiapine Rispéridone Récepteur α-adrénergique Toxicité Tranquillisant Ziprasidone Etats-Unis Agoniste partiel Antagoniste dopamine Antagoniste sérotonine Antagoniste Benzisoxazole dérivé Dérivé de la dibenzothiazépine Dérivé de la phénothiazine Dérivé de la pipérazine Pathologie de l'appareil génital mâle Pathologie de l'érection Quinolinone dérivé Récepteur dopaminergique D2 Récepteur sérotoninergique 5-HT1A Récepteur sérotoninergique 5-HT2 Récepteur sérotoninergique 5-HT2A Récepteur sérotoninergique Traitement Amérique du Nord Amérique
- Keyword (en)
- Atypical antipsychotic Antipsychotic Aripiprazole Database Chlorpromazine Secondary effect Etiopathogenesis Human Hypnotic Drug Neuroleptic Pharmacotherapy Pharmacovigilance Priapism Psychotropic Quetiapine Risperidone α-Adrenergic receptor Toxicity Tranquillizer Ziprasidone United States Partial agonist Dopamine antagonist Serotonin antagonist Antagonist Benzisoxazole derivatives Dibenzothiazepine derivatives Phenothiazine derivatives Piperazine derivatives Male genital diseases Erection disorders Quinolinone derivatives D2 Dopamine receptor 5-HT1A Serotonine receptor 5-HT2 Serotonine receptor 5-HT2A serotonin receptor Serotonine receptor Treatment North America America
- Keyword (es)
- Antipsicótico atípico Antipsicótico Aripiprazol Base dato Clorpromazina Efecto secundario Etiopatogenia Hombre Hipnótico Medicamento Neuroléptico Farmacoterapia Farmacovigilancia Priapismo Psicotropo Quetiapina Risperidona Receptor α-adrenérgico Toxicidad Tranquilizante Ziprasidona Estados Unidos Agonista parcial Antagonista dopamina Antagonista serotonina Antagonista Benzisoxazol derivado Dibenzotiazepina derivado Fenotiazina derivado Piperazina derivado Aparato genital macho patología Erección patología Quinolinona derivada Receptor dopaminérgico D2 Receptor serotoninérgico 5-HT1A Receptor serotoninérgico 5-HT2 Receptor serotoninérgico 5-HT2A Receptor serotoninérgico Tratamiento America del norte America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A06 Clinical trial. Drug monitoring
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20B Male genital diseases / 002B20B01 Non tumoral diseases
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…
- Discipline
- General pharmacology Gynecology. Andrology. Obstetrics Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 22331675
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"68\";s:8:\"\u0000*\u0000epage\";s:2:\"71\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ANDERSOHN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Frank\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:15:\"SCHMEDT, Niklas\";i:1;s:16:\"WEINMANN, Stefan\";i:2;s:17:\"WILLICH, Stefan N\";i:3;s:16:\"GARBE, Edeltraut\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"68\";s:8:\"\u0000*\u0000epage\";s:2:\"71\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ANDERSOHN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Frank\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:15:\"SCHMEDT, Niklas\";i:1;s:16:\"WEINMANN, Stefan\";i:2;s:17:\"WILLICH, Stefan N\";i:3;s:16:\"GARBE, Edeltraut\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"68\";s:8:\"\u0000*\u0000epage\";s:2:\"71\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ANDERSOHN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Frank\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:15:\"SCHMEDT, Niklas\";i:1;s:16:\"WEINMANN, Stefan\";i:2;s:17:\"WILLICH, Stefan N\";i:3;s:16:\"GARBE, Edeltraut\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"68\";s:8:\"\u0000*\u0000epage\";s:2:\"71\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ANDERSOHN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Frank\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:15:\"SCHMEDT, Niklas\";i:1;s:16:\"WEINMANN, Stefan\";i:2;s:17:\"WILLICH, Stefan N\";i:3;s:16:\"GARBE, Edeltraut\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"68\";s:8:\"\u0000*\u0000epage\";s:2:\"71\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ANDERSOHN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Frank\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:15:\"SCHMEDT, Niklas\";i:1;s:16:\"WEINMANN, Stefan\";i:2;s:17:\"WILLICH, Stefan N\";i:3;s:16:\"GARBE, Edeltraut\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Priapism Associated With Antipsychotics: Role of \u03b1 1 Adrenoceptor Affinity\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
